Washington, DC (July 08, 2024)— The following is a joint Statement from the National Kidney Foundation (NKF) and American Society of Nephrology (ASN) on the Organ Procurement and...
Statement from the NKF on House Energy and Commerce Committee Advancing the Honor Our Living Donors (HOLD) Act (H.R. 6020)
Washington, DC (June 12, 2024)—The following is a statement from...
Survey highlights growing epidemic of hypertension and the urgent need for additional treatment options to lower blood pressure
(May 29, 2024, NEW YORK, NY) - A survey recently conducted...
Long Beach, CA - May 16, 2024 - A new analysis of a study comparing two commonly used medications, chlorthalidone (CTD) and hydrochlorothiazide (HCTZ), is set to be presented as a late-...
Long Beach, CA - May 15, 2024 - A new study to shed light on the long-term nephroprotective potential of sparsentan compared to maximally titrated irbesartan (MT-IRB) in patients with IgA...
(May 14, New York, NY) – During a late-breaking abstract presentation at the annual 2024 NKF Spring Clinical Meetings (SCM) tomorrow Dr. Dana Rizk, from the University of Alabama at...